Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01379716 · ClinicalTrials.gov registry record · NA

Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls

A NA study, sponsored by Albany Medical College.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT01379716: Completed NA study, sponsored by Albany Medical College.

NCT01379716 is a NA study that has completed, run by Albany Medical College. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01379716, a NA study, has completed, sponsored by Albany Medical College.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Postherpetic Neuralgia is a painful nerve condition that can occur when nerve fibers are damaged following an outbreak of shingles. The purpose of this study is to identify and study abnormalities in the nerves and cells in the of patients with postherpetic Neuralgia (PHN) and characterize changes that could be responsible for causing nerve pain. This data will be compared to the tissue of healthy volunteers. Our goal is that this information will lead to the development of better treatment options for people with painful nerve conditions.

Primary Outcome

The skin biopsies will be used to identify the site of expression of selected makers in skin, including nerve fibers and skin substructures in patients with PHN and age and gender-atched normal controls.

Interventions

  • OTHER skin biopsy

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2011-01
Est. Completion 2013-06
Phase NA
Albany Medical College

52 total trials

What the finished NCT01379716 record still lists

NCT01379716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which skin biopsy is the first listed.

NCT01379716 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01379716 about?

NCT01379716 is a clinical study titled "Evaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy Controls". Postherpetic Neuralgia is a painful nerve condition that can occur when nerve fibers are damaged following an outbreak of shingles. The purpose of this study is to identify and study abnormalities in the nerves and cells in the of patients with postherpetic Neuralgia (PHN) and characterize changes ...

What is the current status of trial NCT01379716?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2011-01. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01379716?

The interventions under investigation include: skin biopsy (OTHER).

Who is sponsoring clinical trial NCT01379716?

This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01379716's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01379716, the US trial registry maintained by the National Library of Medicine. NCT01379716 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.